A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2001
11/21/2001	CN1323310A Photocyclized rapamycins
11/21/2001	CN1323309A Phenyl yanthine derivatives
11/21/2001	CN1323302A N-cimidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
11/21/2001	CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1323202A Sertraline oral concentrate
11/21/2001	CN1323201A Extended release buccal bioadhesive tablet
11/21/2001	CN1322725A Indole derivant
11/21/2001	CN1322724A Isoflavane compound in spherophys and its medicine application
11/21/2001	CN1322557A Medicine for treating cardiac and cerebral vascular disease and hypertension and its preparation process
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1322474A Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process
11/21/2001	CN1074926C Antiarrhythmic benzodiazepines
11/21/2001	CN1074920C Analgesic agent and its use
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6319955 And a non-mek1 inhibitor anti-stroke agent selected from the group consisting of n-methyl-d-aspartate (nmda) receptor antagonists, immunosuppressants and caspase inhibitors
11/20/2001	US6319934 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319520 Copolymers of ammonium methacrylate that consist of fully polymerized copolymers of acrylic acid and methacrylic acid ester having quaternary ammonium groups
11/20/2001	US6319513 Oral liquid mucoadhesive compounds
11/20/2001	US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer
11/20/2001	CA2174854C Quinazoline derivative
11/15/2001	WO2001085984A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085959A2 Regulation of human lysostaphin-like protease
11/15/2001	WO2001085956A2 Lipid metabolism enzymes
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001	WO2001085726A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001	WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001	WO2001085702A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/15/2001	WO2001085701A1 5-ht7 receptor antagonists
11/15/2001	WO2001085698A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085691A1 Anthranylalkyl and cycloalkyl amides and use thereof as vegf receptor inhibitors
11/15/2001	WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085668A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
11/15/2001	WO2001085256A2 Critical illness neuropathy
11/15/2001	WO2001085227A2 Nitric oxide-releasing metallic medical devices
11/15/2001	WO2001085201A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
11/15/2001	WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001	WO2001085193A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	WO2001085155A1 Method and compositions for inhibiting arteriosclerosis
11/15/2001	WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
11/15/2001	WO2001085145A2 A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
11/15/2001	WO2001085100A2 Vasodilator-thrombolytic fusion proteins and conjugates
11/15/2001	WO2001085094A2 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
11/15/2001	WO2001085093A2 Compounds and methods for modulating cerebral amyloid angiopathy
11/15/2001	WO2001084929A1 Antitubulin assembly and cell growth inhibitor denominated 'dioxostatin'
11/15/2001	WO2001060375A8 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration
11/15/2001	WO2001042794A3 Method for identifying inhibitors of cytokinesis
11/15/2001	WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001	WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001	WO2001019334A3 Pharmaceutical solutions of levosimendan
11/15/2001	WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands
11/15/2001	WO2001016136B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000071507A3 INHIBITORS OF FACTOR Xa
11/15/2001	WO2000050068A3 Elastin-based compositions
11/15/2001	US20010041809 Novel forms of pravastatin sodium
11/15/2001	US20010041730 (1S,2S)-2-(2-(N-((3-benzoimidazol-2-yl)propyl)-N-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy
11/15/2001	US20010041729 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041705 Heterocyclic carboxamides
11/15/2001	US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001	US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001	US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001	US20010041688 Methods and compositions for the regulation of vasoconstriction
11/15/2001	US20010041679 Multiple site delivery of adenoviral vector for the induction of angiogenesis
11/15/2001	US20010041673 A purine derivative or salt, useful for treating heart related diseases including congestive heart failure in mammals, particularly in human
11/15/2001	US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001	US20010041184 Silanized stainless steel surface coupled to nucleophilic amine residues then reacted with nitric oxide gas
11/15/2001	US20010041170 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
11/15/2001	DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001	DE10022510A1 Composition used as folate source in food, feed, nutritional supplements or medicaments, e.g. for prophylaxis of cardiovascular disease includes folic acid and 5-methyl-tetrahydrofolic acid
11/15/2001	CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof
11/15/2001	CA2415688A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals

1 ... 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 ... 1595